Targeting Alzheimer's with Novel Therapeutics
Loews Philadelphia Hotel
1200 Market Street
Philadelphia, PA
Targeting Alzheimer's with Novel Therapeutics
Cambridge Healthtech Institute

Schedule of Presentations:

Wednesday, June 10, 2009
07:15:00 Check-In
12:00:00 New Presentation
13:55:00 Chairperson’s Remarks Sharon Shacham
14:00:00 Brain Mitochondria as a Primary Target in the Development of Treatment Strategies for Alzheimer Disease Gjumrakch Aliev
14:30:00 Genotype-Specific Therapeutic Responses in Alzheimer’s Disease Lauren C Costantini
15:00:00 Blocking RTN3 Aggregation as a Therapeutic Target of Alzheimer’s Treatment Riqiang Yan
15:30:00 Sponsored Presentation (Opportunity Available)
15:45:00 Networking Refreshment Break in the Exhibit Hall
16:30:00 PRX-03140: A Novel, Highly Selective, Small-Molecule Agonist of a Specific GPCR Known as 5-HT4 Sharon Shacham
17:00:00 Will β Amyloid Continue to Be a Feasible Alzheimer’s Target?
17:30:00 End of Day
Thursday, June 11, 2009
08:00:00 Registration Open
08:00:00 Morning Coffee
08:30:00 Chairperson’s Remarks Timothy A. Esbenshade
08:40:00 Potential Efficacy of Tau Aggregation Inhibitor Therapy with remberTM in Alzheimer’s Disease Claude M. Wischik
09:10:00 Apolipoprotein-E Mimetics Increase PP2a and Reduce Alzheimer’s Pathology Michael Vitek
09:40:00 Tau Phosphorylation and Synaptic Degeneration Frank Striggow
10:10:00 Networking Coffee Break in the Exhibit Hall
10:55:00 Big Pharma’s Approach to Tau Michael L. Hutton
11:25:00 The Histamine H3 Receptor: An Attractive Target for the Treatment of Cognitive Disorders Timothy A. Esbenshade
11:55:00 Luncheon Presentation
12:55:00 Session Break
13:25:00 Chairperson’s Remarks Varghese John
13:30:00 Novel Therapeutic Approaches Based on APP Signaling Varghese John
14:00:00 Leptin as a Novel Alzheimer’s Disease Therapeutic Steven J. Greco
14:30:00 TNF Modulation for Treatment of Alzheimer’s Disease Edward Tobinick
15:00:00 Ice Cream Refreshment Break in the Exhibit Hall
15:40:00 Small Molecule Effects on Proliferation and Differentiation of Adult Neural Stem Cells Gilbert Rishton
16:10:00 Dimebon: Turning an Old Drug to a New Use Lynn Seely
16:40:00 Lead Identification of Acetylcholinesterase Inhibitors–Histamine H3 Receptor Antagonists from Molecular Modeling Scott D. Bembenek
17:10:00 Close of Targeting Alzheimer’s with Novel Therapeutics
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.